Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Gastric Cancer × Irinotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 31 Pancreatic Neoplasms 14 Colonic Neoplasms 11 Stomach Neoplasms 9 Rectal Neoplasms 9 Neoplasms 8 Small Cell Lung Carcinoma 7 Neuroblastoma 7 Glioblastoma 7 Sarcoma, Ewing 6 Rhabdomyosarcoma 6 Neoplasm Metastasis 6 Carcinoma, Non-Small-Cell Lung 6 Central Nervous System Neoplasms 5 Glioma 4 Gastrointestinal Neoplasms 4 Advanced Solid Tumors 4 Sarcoma 3 Medulloblastoma 3 Gliosarcoma 3 Brain Neoplasms 3 Astrocytoma 3 Recurrence 2 Rectal Diseases 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasms by Site 2 Metastatic Pancreatic Adenocarcinoma 2 Intestinal Neoplasms 2 Intestinal Diseases 2

Interventions

apatinib 3 camrelizumab 2 Paclitaxel 2 Irinotecan 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01136031 2015-05-20

TI-2ndAGC

Seoul National University Hospital

Phase 1/2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡